• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The growing burden of long COVID in the United Kingdom: Insights from the UK Coronavirus Infection Survey
Source: International Forum of Allergy and Rhinology - December 8, 2022 Category: Allergy & Immunology Authors: Shyam Ajay Gokani, Ngan Hong Ta, Andreas Espehana, Elizabeth Mairenn Garden, Gabija Klyvyte, Louis Luke, Tharsika Myuran, Vinushy Uththerakunaseelan, Duncan Cameron Boak, Carl Martin Philpott Tags: RESEARCH NOTE Source Type: research

Risk of serious COVID-19 outcomes among adults and children with moderate-to-severe asthma: a systematic review and meta-analysis
Conclusions Adults with severe asthma are at increased risk of COVID-19 hospitalisation compared to nonusers. Our analysis highlighted the dearth of studies in children with asthma investigating serious COVID-19 outcomes.
Source: European Respiratory Review - November 2, 2022 Category: Respiratory Medicine Authors: Lee, B., Lewis, G., Agyei-Manu, E., Atkins, N., Bhattacharyya, U., Dozier, M., Rostron, J., Sheikh, A., McQuillan, R., Theodoratou, E., for the Usher Network for COVID-19 Evidence Reviews (UNCOVER) group Tags: Asthma and allergy Reviews Source Type: research

News at a glance: New gene therapy, Europe ’s drought, and a black hole’s photon ring
ARCHAEOLOGY Drought exposes ‘Spanish Stonehenge’ for study Scientists are rushing to examine a 7000-year-old stone circle in central Spain that had been drowned by a reservoir for decades and was uncovered after the drought plaguing Europe lowered water levels. Nicknamed the “Spanish Stonehenge”—although 2000 years older than the U.K. stone circle—the Dolmen of Guadalperal (above) was described by archaeologists in the 1920s. The approximately 100 standing stones, up to 1.8 meters tall and arranged around an oval open space, were submerged in the Valdecañas reservoir after the construction of a ...
Source: Science of Aging Knowledge Environment - August 25, 2022 Category: Geriatrics Source Type: research

Johnson & Johnson Expands Phase 2a Clinical Trial of COVID-19 Vaccine Candidate to Include Adolescents
New Brunswick, NJ (April 2, 2021) – Johnson & Johnson (the Company) has begun vaccinating adolescent participants in the ongoing Phase 2a clinical trial for its COVID-19 vaccine candidate, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. “The COVID-19 pandemic has had a profound impact on adolescents, not just with the complications of the disease, but with their education, mental health, and wellbeing,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson. “It is vital that we develop vaccines for everyone, everywher...
Source: Johnson and Johnson - April 2, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

PNR Weekly Digest: March 30, 2021
Items regarding COVID-19 information are indicated with an * In the Dragonfly: *NNLM Covid-19 Symposium. Keynote Speakers Announced. Registration is Open The Network of the National Library of Medicine (NNLM) is excited to announce a new, free virtual symposium focused on addressing the COVID-19 infodemic in our communities. The NNLM Virtual Symposium: Responding to the COVID-19 Infodemic is an opportunity to address misinformation and mistrust, raise awareness about the pandemic, and efforts to combat it. Symposium attendees can expect to come away from the 2-day experience with a better understanding of COVID-19 and shar...
Source: Dragonfly - March 30, 2021 Category: Databases & Libraries Authors: Carolyn Martin Tags: PNR Weekly Digest Source Type: news

Severe acute respiratory syndrome coronavirus 2 infection in those on mepolizumab therapy
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),1 continues to cause morbidity and mortality across the world. The expert recommendation is to continue biologic therapy unchanged in severe eosinophilic asthma2,3 but concern has been expressed as eosinopenia may be a risk factor for worse disease outcomes.4,5 Here, we report the outcomes of 4 patients from centers in the United Kingdom, Italy, and North America with COVID-19, while receiving treatment with mepolizumab, an anti –interleukin 5 monoclonal antibody, which reduces eosinophils to within the reference range.
Source: Annals of Allergy, Asthma and Immunology - January 12, 2021 Category: Allergy & Immunology Authors: Adnan Azim, Laura Pini, Zeeshan Khakwani, Santosh Kumar, Peter Howarth Tags: Letters Source Type: research

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!” I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed. This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Health - January 11, 2021 Category: Consumer Health News Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news

California Has the Second Confirmed Case of the Coronavirus Variant in the U.S.
California on Wednesday announced the nation’s second confirmed case of the new and apparently more contagious variant of the coronavirus, offering a strong indication that the infection is spreading more widely in the United States. Gov. Gavin Newsom announced the infection found in Southern California during an online conversation with Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases. “I don’t think Californians should think that this is odd. It’s to be expected,” Fauci said. Newsom did not provide any details about the person who was infected. The announc...
Source: TIME: Health - December 31, 2020 Category: Consumer Health News Authors: COLLEEN SLEVIN and CARLA K. JOHNSON / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news

Top Global Health Moments of 2020
By The Editorial Team, IntraHealth International Community Health Nurse Olivia Yeboah thoroughly washes her hands at the Akropong Clinic in Ghana. Photo by Emmanuel Attramah, PMI Impact Malaria/US President ' s Malaria Initiative.December 17, 2020If we wanted to, we could list a COVID-19 moment for every month of 2020.  We all know that the onset of the coronavirus pandemic—first in China and then worldwide—overwhelmed news coverage this year. And with good reason. It’s the first large-scale global pandemic in 100 years. At the time this article was pu...
Source: IntraHealth International - December 17, 2020 Category: International Medicine & Public Health Authors: kseaton Tags: HIV & AIDS COVID-19 Nutrition Policy Advocacy Health Workforce Systems Nursing Midwifery 2020 Health Workers Source Type: news

Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects. On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week. Related: Emergency Considerations in COVID-19 Vaccine Administration In the U.S., vaccine recipients are supposed ...
Source: JEMS Patient Care - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Pages: 1  2  3